Gara Jalqabaatti › Myeloma Baay’ee › Connecticut › New Haven
Qorannoo klinikaalii Myeloma Baay’ee New Haven, CT keessatti
Qorannoo 14 Myeloma Baay’ee f New Haven fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · Miili 7 fagaatti
- Smilow Cancer Hospital-Derby Care Center, Derby · Miili 8 fagaatti
- fi 1 dabalataa
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, New Haven
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 3
- Yale Cancer Center, New Haven
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Namoota walitti qabaa jiraSadarkaa 2
- Yale University School Of Medicine, New Haven
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 3
- Yale New Haven Hospital, New Haven
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Namoota walitti qabaa jiraSadarkaa 1/2
- Smilow Cancer Center At Yale-New Haven /ID# 272447, New Haven
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 3
- Yale University, New Haven
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1/2
- Yale New Haven Hospital-Smilow Cancer Center, New Haven
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Namoota walitti qabaa jiraSadarkaa 3
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Smilow Cancer Hospital-Orange Care Center, Orange · Miili 5 fagaatti
- fi 3 dabalataa
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, New Haven
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Namoota walitti qabaa jiraSadarkaa 3
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · Miili 7 fagaatti
- fi 2 dabalataa
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Namoota walitti qabaa jiraSadarkaa 3
- Yale New Haven Hospital, New Haven
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
Namoota walitti qabaa jiraSadarkaa 2
- Yale University, New Haven
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1
- Yale Cancer Center, New Haven
Qorannoo Myeloma Baay’ee magaalota biroo keessatti
- New York City, NYQorannoo 60
- Boston, MAQorannoo 42
- Atlanta, GAQorannoo 42
- Houston, TXQorannoo 38
- Durham, NCQorannoo 37
- Nashville, TNQorannoo 32
- Denver, COQorannoo 27
- Rochester, MNQorannoo 24
- St. Louis, MOQorannoo 24
- Columbus, OHQorannoo 24
- Baldwin Park, CAQorannoo 23
- Edison, NJQorannoo 22
Qorannoo biroo New Haven keessatti
- Kansara Qara'a Non-Small CellQorannoo 41
- Saree OljooQorannoo 38
- Saree (Gosoota Hunda)Qorannoo 33
- Kansara MetastatikiiQorannoo 23
- Dhibee QaraQorannoo 22
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 22
- Kansarii OvariiQorannoo 21
- Kansarii ColorectalQorannoo 20
- Kansarii ProstateQorannoo 20
- Leukemia Myeloidii HamaaQorannoo 17
- Alcohol Use Disorder (AUD)Qorannoo 17
- Overdose OpioidQorannoo 17
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.